Navigation Links
Novagali Pharma Announces the Launch of Cationorm(R)
Date:4/9/2008

The Innovative Cationic Emulsion for the Treatment of Dry Eye Symptoms

An Optimal Solution for Patients

The First Product Developed From its Pipeline to be Marketed

EVRY, France, April 9 /PRNewswire/ -- Novagali Pharma, an ophthalmic specialty pharmaceutical company announces the commercial launch in France of its first product Cationorm(R). This cationic emulsion is an innovative approach to treat dry eye symptoms. It has been developed on the basis of Novagali Pharma patented technology platform Novasorb(R).

Dry eye syndrome is the second cause of consultation in ophthalmology. It concerns over 100 million people in the world and 14% of the adults of more than 40 years. Due to a chronic lack of lubrication and moisture in the eye, its consequences range from irritation to ocular inflammation of the conjunctiva and corneal tissues of the eyes. People with dry eye have sandy-gritty irritation or burning in their eyes. In most severe cases, corneal lesions may lead to vision loss. Specific factors such as ageing populations, pollution, air conditioning, extended use of computers, contribute to an increase in the prevalence of the syndrome and in opportunities for the development of more efficient products.

Cationorm(R) brings a true innovation to the patients suffering from dry eye symptoms. The cationic emulsion reproduces the tear mechanisms of action to act on the different levels of the tear film. Cationorm(R) uniquely combines lubricating and hydrating properties, optimal spreading on the surface of the eye, replenishment of the tear film lipid layer and prevention of tear evaporation. The results of clinical study have clearly demonstrated Cationorm(R) advantages for patients: tolerance, long-lasting relief and optimal comfort.

These advantages are based on Novasorb(R), the proprietary cationic emulsion technology platform of Novagali Pharma. Novasorb(R), is designed to improve topical administ
'/>"/>

SOURCE Novagali Pharma
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...LE, Calif., Oct. 10 /- Neur...NTII ), today announced it will hold a,conference ...n the,Viprinex(TM) (ancrod) Phase 3 Trial Program ...e Paul E. Freiman, president and chief executive,o...cer., -- Date: Monday, October 13, 2008 -- Ti...
(Date:10/10/2008)...searchers in academia and industry reveal powerful...Lacromin) in mammalian cell culture lea...T COLLINS, Colo., Oct. 10 /- A recent...tro Cellular & Developmental Biology,revealed that..., http://www.Lacromin.com ) is a strong growth fac...
(Date:10/10/2008)...HRISTI, Texas, Oct. 10 /- C..., a technology management,company, announced the c...ent. The approval is on a key divisional applicati...ing High Frequency Electric Current,Therethrough" ...cts ("LTC"),platform tissue bonding/welding techno...
(Date:10/10/2008)...Mass., Oct. 10 /- Boston Sc... it has received approval from the,U.S. Food and D...ration,TAXUS(R) Liberte(R) Paclitaxel-Eluting Coro... TAXUS Liberte stent early next month in the Unite... of its TAXUS(R),Expresss2(TM) Atom(TM) Paclitaxel...
Breaking Biology Technology:Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 3Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 3
...ives of Sentry Insurance are recruiting informa...t will open in the Fox Valley earlier next year. ,...its information technology operations in the valle...provements to U.S. Highway 10, which connects the ... Valley communities. , ,The office, which will em...
...ologies, Inc . has signed an agreement with an ins....9 million through the private placement of conver...eeds for general corporate purposes. , ,According...roximately 2.48 million shares of its common stock...he notes carry a yield to maturity of six percent ...
...ace agency announced this month it wants to return...for the longer trip to Mars . Others say the Nat... bypass the Earth,s lifeless satellite and head ...lizing signs of water. Still others say the govern...t and let private entrepreneurs figure it out. , ,...
...djari could serve as an inspiration for anyone who...s, but his four-year-old venture is no ordinary co...blished a $5 million annual business called the C...e, one that is helping the United States defend it...t wasn,t always residential. He has more than 20 y...
Other Biology Technology:Flying to the moon? Take Wisconsin tech along 2Flying to the moon? Take Wisconsin tech along 3Flying to the moon? Take Wisconsin tech along 4Internet security is big business for Wisconsin Rapids firm 2Internet security is big business for Wisconsin Rapids firm 3Internet security is big business for Wisconsin Rapids firm 4
(Date:10/12/2008)...e found a new possible explanation for why people ...ion against the spread of cancers. , They have s...n all fruits and vegetables, binds to and is belie...lays a role in all stages of cancer progression. ,...s are based on population studies," says Professor...
(Date:10/12/2008)...ure Nanotechnology journal (October 12th) reveals...hnology (LCN) at UCL are using a novel nanomechani...ycin, one of the few antibiotics that can be used ...s MRSA. The researchers, led by Dr Rachel McKendry...sitive probes capable of providing new insight int...
(Date:10/10/2008)...entified stem cells with the capacity to build fat...of the journal Cell, a Cell Press publication. A...enew themselves, transplants of the progenitor cel... restore normal fat tissue in animals that are oth...t into the causes of obesity, a condition characte...
(Date:10/10/2008)...tion technology have shaped not only how we find o...cines. A project just funded by the National Insti...design to the next level. , The University of Mi...the molecular data needed to develop computer prog...andidates. The data will be housed in a Web-based ...
Breaking Biology News(10 mins):Pectin power 2Nanotechnology boosts war on superbugs 2Fat-regenerating 'stem cells' found in mice 2New data resource to advance computer-aided drug design 2PPD Announces Plan to Repurchase Shares of its Common Stock 3436 1PPD Announces Plan to Repurchase Shares of its Common Stock 3436 2Cadence Pharmaceuticals Completes 2449 3 Million Registered Direct Offering 3432 1Cadence Pharmaceuticals Completes 2449 3 Million Registered Direct Offering 3432 2Cadence Pharmaceuticals Completes 2449 3 Million Registered Direct Offering 3432 3NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars says MIM President Bob Peters 1398 1NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars says MIM President Bob Peters 1398 2Scientists make first map of emerging disease hotpsots 12381 1Scientists make first map of emerging disease hotpsots 12381 2Scientists make first map of emerging disease hotpsots 12381 3
... Medical Center implanted Artificial Silicon Retin... treat vision loss caused by retinitis pigmentosa ...ameter and one-thousandth of an inch thick, less t...s had surgery Tuesday, January 25. The fifth patie... investigator Dr. John Pollack performed the surge...
...bright, light-emitting molecules have enabled rese...ter below the skin surface using only infrared lig...esearchers based at the University of Pennsylvania...scent materials called porphyrins within the surfa... a tumor within a living rodent. Their findings, w...
... to humane alternatives to the use of animals in r...wn that requires using animals as part of the test... Committee for Responsible Medicine, you invent yo... announced today that PCRM has developed the world...o measure insulin levels in individuals with diabe...
...searchers have identified several genetic changes ... help researchers better understand how and why pe...sue of the Journal of Neuroscience, researchers re...ion patterns regulated by alcohol in two mouse str...fer in a number of behavioral responses to acute a...
Other Biology News:Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss 2Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss 3Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin 2PCRM develops world's first cruelty-free insulin assay 2VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 2VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 3
Source of colony stimulating factors for assays of mouse hematopoietic progenitors from bone marrow, spleen, blood and fetal liver. Suitable for the growth of mouse BFU-E, CFU-M, CFU-G and CFU-GEMM
MagNA Pure LC Instrument from Roche Applied Science
Piperazine-N',N'-bis(2-ethanesulfonic acid), monosodium salt
...the principal excitatory neurotransmitter receptor...st: Ionotropic receptors, and metabotropic recepto...complexes of various subunits (GluR1-7, NMDA1-3, K.... Metabotropic glutamate receptors are G-protein c...
Biology Products: